Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccination—A Retrospective Cohort Study

SIMPLE SUMMARY: Patients with B-cell malignancies benefit from the third vaccination against SARS-CoV-2 with regards to antibody production. In this cohort, patients with B-cell malignancies experienced greater difficulties in developing neutralizing antibodies, particularly under active treatment w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wirth, Stella Rosa Maria, Podar, Klaus, Pecherstorfer, Martin, Wohlfarth, Philipp, Jaeger, Ulrich, Singer, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856293/
https://www.ncbi.nlm.nih.gov/pubmed/36672473
http://dx.doi.org/10.3390/cancers15020524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856293/
https://www.ncbi.nlm.nih.gov/pubmed/36672473
http://dx.doi.org/10.3390/cancers15020524

Ejemplares similares